sr141716 has been researched along with linoleoyl ethanolamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avraham, Y; Berry, EM; Ezra, AF; Grigoriadis, NC; Harfoush, F; Katzhendler, J; Kunkes, E; Listman, C; Merchavia, S; Najajreh, Y; Salameh, S; Vorobeiv, L | 1 |
1 other study(ies) available for sr141716 and linoleoyl ethanolamide
Article | Year |
---|---|
Novel acylethanolamide derivatives that modulate body weight through enhancement of hypothalamic pro-opiomelanocortin (POMC) and/or decreased neuropeptide Y (NPY).
Topics: Amides; Animals; Anti-Obesity Agents; Body Weight; Eating; Ethanolamines; Female; Hypothalamus; Mice; Mice, Inbred C57BL; Mice, Obese; Neuropeptide Y; Nuclear Magnetic Resonance, Biomolecular; Oleic Acids; Pro-Opiomelanocortin; Valine | 2013 |